Natural history of colorectal carcinoma: Can the tumor volume doubling time be predicted by radiologic findings or immunohistochemical variables?

Journal of Surgical Oncology

Volumn 68, Issue 4, 1998, Pages 215-224

  Iwashita, Ikuko ^a   Ueyama, Toshihiko ^a   Iwashita, Akinori ^b   Kawamoto, Kenji ^a   Kitagawa, Shinji ^b   Motooka, Makoto ^a   Utsunomiya, Takashi ^a   Masuda, Kouji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cellular proliferative activity; Colon carcinoma; Growth rate; Tumor suppressor gene

Indexed keywords

CYCLINE; KI 67 ANTIGEN; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DIAGNOSTIC IMAGING; FEMALE; GENE ACTIVITY; GROWTH RATE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CELL DIVISION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031818525     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199808)68:4<215::AID-JSO3>3.0.CO;2-7     Document Type: Article

References (48)

1. Collins VP: Time of occurrence of pulmonary metastasis from carcinoma of the colon and rectum. Cancer 1961;15:387-395.
2. Collins VP, Loeffer RK, Tivey H: Observation on growth rates of human tumors. Am J Roentgenol 1956;76:988-1000.
3. Welin S, Youker J, Spratt JS, et al.: The rates and patterns of growth of 375 tumors of the large intestine and rectum observed serially by double contrast enema study (Malmö technique). Am J Roentgenol 1963;90:673-687.
4. Bolin S, Nilsson E, Sjödahl R: Carcinoma of the colon and rectum-Growth rate. Am Surg 1983;198:151-158.
5. Burnett HR, Greenbaum EI: Rapidly growing carcinoma of the colon. Dis Colon Rectum 1981;24:282-286.
6. Jass JR, Atkin WS, Cuzick J, et al.: The grading of rectal cancer: Historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437-459.
7. Stähle E, Enblad P, Pählman L, et al.: Can mortality from rectal and rectosigmoid carcinoma be predicted from histopathological variables in the diagnostic biopsy? Acta Pathologica Microbiologica et Immunologica Scandinavica 1989;97:513-522.
8. Wiggers T, Arends JW, Schutte B, et al.: A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988;61:386-395.
9. Fisher ER, Paik SM, Rockette H, et al.: Prognostic significance of eosinophils and mast cells in rectal cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). Hum Pathol 1989;20:159-163.
10. Shepherd NA, Saraga EP, Love SB, et al.: Prognostic factors in colonic cancer. Histopathology 1989;14:613-620.
11. Moore PA, Dilawari RA, Fidler WJ: Adenocarcinoma of the colon and rectum in patients less than 40 years of age. Am Surg 1984;50:10-14.
12. Johnston PG, Mrcpi MB, O'Brien MJ, et al.: Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum Pathol 1989;20:696-700.
13. Wada R, Miwa H, Abe H, et al.: The possible association between expression of p53 and development in depressed type colorectal carcinoma. Acta Histochem Cytochem 1993;26:21-25.
14. Porschen R, Lohe B, Hengels KJ, et al.: Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki-67. Cancer 1989;64:2501-2505.
15. Kubota Y, Petras RE, Easley KA, et al.: Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer 1992;70:2602-2609.
16. Linden MD, Ma CK, Kubus J, et al.: Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 1993;100:206-212.
17. Porschen R, Kriegel A, Langen C, et al.: Assessment of proliferative activity in carcinomas of the human alimentary tract by Ki-67 immunostaining. Int J Cancer 1991;47:686-691.
18. Suzuki H, Matsumoto K, Terabe M: Ki-67 antibody labeling index in colorectal carcinoma. J Clin Gastroenterol 1992;15:317-320.
19. Risio M, Rossini FP: Cell proliferation in colorectal adenomas containing invasive carcinoma. Anticancer Res 1993;13:43-48.
20. Berenzi A, Benetti G, Bertalot G, et al.: Ki-67 immunohistochemical evaluation in colorectal cancer and normal colonic mucosa. Possible clinical applications. Pathologica 1992;84:155-163.
21. Ogura S, Abe S, Sukoh N, et al.: Correlation between nuclear organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma. Cancer 1992;70:63-68.
22. Japanese Research Society for Cancer of the Colon and Rectum: "General Results for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus." 5th Ed. Tokyo: Kanehara Press, 1994.
23. Spratt JS, Ackerman LV: The growth of a colonic adenocarcinoma. Am Surg 1961;27:23-28.
24. Kusama S, Spratt JS Jr, Donegan WL, et al.: The gross rates of growth of human mammary carcinoma. Cancer 1972;30:594-599.
25. Borrmann R: Geschwülste des Magens und duodenums. In Henke F, Lubarsch O (eds): "Handbuch der Speziellen Pathologischen Anatomie und Histologie." Berlin: Springer, 1926;4:864-871.
26. Figiel LS, Figiel SJ, Wietersen FK: Roentgenologic observations of growth rates of colonic polyps and carcinoma. Acta Radiol Diagn 1965;3:417-429.
27. Shackney SE, Mccormack GW, Cuchural GJ Jr, et al.: Growth rate patterns of solid tumors and their relation to responsiveness to therapy. Ann Intern Med 1978;89:107-121.
28. Ushio K, Ishikawa T: Natural history of colorectal cancer based on retrospective radiographic analysis. Adv Gastrointest Radiol 1992;2:83-97.
29. Diller L, Kassel J, Nelson CE, et al.: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 1990;10:5772-5781.
30. Milner J, Medcalf EA: Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 1991;65:765-774.
31. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
32. Baker SJ, Fearon ER, Nigro JM, et al.: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-221.
33. Baker SJ, Markowitz S, Fearon ER, et al.: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-915.
34. Baker SJ, Preisinger AC, Jessup JM, et al.: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-7722.
35. Bartek J, Iggo R, Gannon J, et al.: Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990;5:893-899.
36. Miyachi K, Fritzler MJ, Tan EM: Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121:2228-2234.
37. Hall PA, Levison DA, Woods AL, et al.: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
38. Yu CCW, Fletcher CDM, Newman PL, et al.: A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nuclear organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumors. J Pathol 1992;166:147-152.
39. Woods AL, Hall PA, Shepherd NA, et al.: The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991;19:21-27.
40. Jain S, Filipe MI, Hall PA, et al.: Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. Clin Pathol 1991;44: 655-659.
41. Gerdes J, Schwab U, Lemke H, et al.: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
42. Gerdes J, Dallenback F, Lennert K: Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol. Oncol. 1984;2:365-371.
43. Gerdes J, Lelle RJ, Pickartz H, et al.: Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 1986;39:977-980.
44. Yonemura Y, Ooyama S, Sugiyama K, et al.: Growth fraction in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer 1990;65:1130-1134.
45. Rosa JC, Mendes R, Filipe MI, et al.: Measurement of cell proliferation in gastric carcinoma. Comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA). Histochem J 1992;24:93-101.
46. Malaise EP, Chavaudra N, Tubiana M: The relationship between growth rate, labelling index and histological type of human solid tumors. Eur J Cancer 1973;9:305-312.
47. Terz JJ, Curutchet HP, Lawrence W Jr: Analysis of the cell kinetics of human solid tumors. Cancer 1971;28:1100-1110.
48. Fujita S: Biology of early gastric carcinoma. Pathol Res Pract 1978;163:297-309.